This study is looking at a new way to identify patients who experience immune-related adverse events (irAEs) (side effects from immunotherapy that happen when your immune system attacks healthy cells). Immunotherapies are treatments that help your own immune system fight cancer. The study wants to see if using a special computer system (informatics system) to automatically check your electronic health records (EHRs) can help find patients with new irAEs more quickly than standard methods. This would help more patients join a biorepository (a collection of samples and data) that studies irAEs. About 100 patients who are receiving or have received immunotherapy for cancer can join this study. The main goals are to see if the computer system is practical to use and if it helps more patients get registered into the biorepository.

Study design

This is a randomized controlled trial involving about 100 participants. It compares an informatics system for eligibility monitoring with standard eligibility monitoring.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study measures feasibility at 2 months and registration at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.